Wikipedia:WikiProject Medicine/Cochrane/Cochrane Review List/Cancer/Urology Group/Spanish results

Urology Group

edit

Cochrane reviews not yet shared on es.Wikipedia.

  • Update performed: January 4 2021

2020-12 Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia PMID 33368143 https://doi.org/10.1002/14651858.CD012867.pub2

2020-12 Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis PMID 33270906 https://doi.org/10.1002/14651858.CD013020.pub2

2020-12 Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer PMID 33314020 https://doi.org/10.1002/14651858.CD013245.pub2

2020-11 Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults PMID 33179245 https://doi.org/10.1002/14651858.CD013393.pub2

2020-10 Targeted therapy for metastatic renal cell carcinoma PMID 33058158 https://doi.org/10.1002/14651858.CD012796.pub2

Aug-20 Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer. PMID 32813279 https://doi.org/10.1002/14651858.CD013641.pub2

Jun-20 Radical prostatectomy versus deferred treatment for localised prostate cancer PMID 32495338 https://doi.org/10.1002/14651858.CD006590.pub3

Mar-20 Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia PMID 32212174 https://doi.org/10.1002/14651858.CD013251.pub2

Feb-20 Water for preventing urinary stones PMID 32045491 https://doi.org/10.1002/14651858.CD004292.pub4

Jan-20 Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer PMID 31912907 https://doi.org/10.1002/14651858.CD011935.pub2

2019-12 Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction PMID 31792928 https://doi.org/10.1002/14651858.CD009629.pub4

2019-10 Medical and surgical interventions for the treatment of urinary stones in children PMID 31596944 https://doi.org/10.1002/14651858.CD010784.pub3

2019-10 Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome PMID 31587256 https://doi.org/10.1002/14651858.CD012552.pub2

Jun-19 Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer PMID 31194882 https://doi.org/10.1002/14651858.CD003506.pub2

May-19 Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy PMID 31111956 https://doi.org/10.1002/14651858.CD013336

May-19 Perioperative nutrition for the treatment of bladder cancer by radical cystectomy PMID 31107970 https://doi.org/10.1002/14651858.CD010127.pub2

May-19 Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma PMID 31102534 https://doi.org/10.1002/14651858.CD013160.pub2

Apr-19 Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer PMID 31022301 https://doi.org/10.1002/14651858.CD012663.pub2

Apr-19 Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction PMID 30953341 https://doi.org/10.1002/14651858.CD012044.pub2

Apr-19 Robotic versus open radical cystectomy for bladder cancer in adults PMID 31016718 https://doi.org/10.1002/14651858.CD011903.pub2

Feb-19 Antimicrobial agents for preventing urinary tract infections in adults undergoing cystoscopy PMID 30789676 https://doi.org/10.1002/14651858.CD012305.pub2

Feb-19 Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi PMID 30726554 https://doi.org/10.1002/14651858.CD012703.pub2

2018-11 Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia PMID 30480763 https://doi.org/10.1002/14651858.CD010060.pub2

2018-10 Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer PMID 30320443 https://doi.org/10.1002/14651858.CD012816.pub2

2018-10 Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia PMID 30306544 https://doi.org/10.1002/14651858.CD007360.pub3

2018-10 Penile rehabilitation for postprostatectomy erectile dysfunction PMID 30352488 https://doi.org/10.1002/14651858.CD012414.pub2

Jul-18 Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review PMID 30036453 https://doi.org/10.1002/14651858.CD012838.pub2

2017-12 Bisphosphonates for advanced prostate cancer PMID 29278410 https://doi.org/10.1002/14651858.CD006250.pub2

2017-11 Medical and dietary interventions for preventing recurrent urinary stones in children PMID 29117629 https://doi.org/10.1002/14651858.CD011252.pub2

2017-11 Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia PMID 29161773 https://doi.org/10.1002/14651858.CD012615.pub2

2017-10 Desmopressin for treating nocturia in men PMID 29055129 https://doi.org/10.1002/14651858.CD012059.pub2

Sep-17 Intravesical electromotive drug administration for non-muscle invasive bladder cancer PMID 28898400 https://doi.org/10.1002/14651858.CD011864.pub2

May-17 Alvimopan for recovery of bowel function after radical cystectomy PMID 28462518 https://doi.org/10.1002/14651858.CD012111.pub2

May-17 Partial nephrectomy versus radical nephrectomy for clinical localised renal masses PMID 28485814 https://doi.org/10.1002/14651858.CD012045.pub2

May-17 Immunotherapy for metastatic renal cell carcinoma PMID 28504837 https://doi.org/10.1002/14651858.CD011673.pub2

Mar-17 Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer PMID 28268259 https://doi.org/10.1002/14651858.CD012112.pub2

Jul-16 Surgery versus non-surgical management for unilateral ureteric-pelvic junction obstruction in newborns and infants less than two years of age PMID 27416073 https://doi.org/10.1002/14651858.CD010716.pub2

2015-10 Citrate salts for preventing and treating calcium containing kidney stones in adults PMID 26439475 https://doi.org/10.1002/14651858.CD010057.pub2

Jun-15 Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic PMID 26120804 https://doi.org/10.1002/14651858.CD006027.pub2

2014-11 Aspiration and sclerotherapy versus hydrocoelectomy for treating hydrocoeles PMID 25391386 https://doi.org/10.1002/14651858.CD009735.pub2

Sep-14 Topical corticosteroids for treating phimosis in boys PMID 25180668 https://doi.org/10.1002/14651858.CD008973.pub2

Jun-14 Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer PMID 24979481 https://doi.org/10.1002/14651858.CD009266.pub2

Feb-14 Dietary interventions for preventing complications in idiopathic hypercalciuria PMID 24519664 https://doi.org/10.1002/14651858.CD006022.pub4

2013-12 Percussion, diuresis, and inversion therapy for the passage of lower pole kidney stones following shock wave lithotripsy PMID 24318643 https://doi.org/10.1002/14651858.CD008569.pub2

2013-12 Psychosocial interventions for men with prostate cancer PMID 24368598 https://doi.org/10.1002/14651858.CD008529.pub3

Aug-13 Antimicrobial therapy for chronic bacterial prostatitis PMID 23934982 https://doi.org/10.1002/14651858.CD009071.pub2

Jan-13 Screening for prostate cancer PMID 23440794 https://doi.org/10.1002/14651858.CD004720.pub3

2012-12 Serenoa repens for benign prostatic hyperplasia PMID 23235581 https://doi.org/10.1002/14651858.CD001423.pub3

Sep-12 Microwave thermotherapy for benign prostatic hyperplasia PMID 22972068 https://doi.org/10.1002/14651858.CD004135.pub3

Aug-12 Pregabalin for chronic prostatitis PMID 22895982 https://doi.org/10.1002/14651858.CD009063.pub2

May-12 Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi PMID 22592707 https://doi.org/10.1002/14651858.CD006029.pub4

Jan-12 Intravesical gemcitabine for non-muscle invasive bladder cancer PMID 22259002 https://doi.org/10.1002/14651858.CD009294.pub2

2011-12 Adjuvant radiotherapy following radical prostatectomy for prostate cancer PMID 22161411 https://doi.org/10.1002/14651858.CD007234.pub2

2011-11 Lycopene for the prevention of prostate cancer PMID 22071840 https://doi.org/10.1002/14651858.CD008007.pub2

Aug-11 Psychosocial interventions for premature ejaculation PMID 21833964 https://doi.org/10.1002/14651858.CD008195.pub2

Jul-11 Low-dose rate brachytherapy for men with localized prostate cancer PMID 21735436 https://doi.org/10.1002/14651858.CD008871.pub2

May-11 Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer PMID 21563157 https://doi.org/10.1002/14651858.CD006885.pub2

Apr-11 Gemcitabine for unresectable, locally advanced or metastatic bladder cancer PMID 21491413 https://doi.org/10.1002/14651858.CD008976.pub2

Apr-11 Surgical management for upper urinary tract transitional cell carcinoma PMID 21491399 https://doi.org/10.1002/14651858.CD007349.pub2

Feb-11 Screening for testicular cancer PMID 21328302 https://doi.org/10.1002/14651858.CD007853.pub2